Label: VITAFOL ONE- vitamin a, ascorbic acid, thiamine mononitrate , riboflavin, niacin, pyridoxine hydrochloride, cyanocobalamin, folic acid, iodine, magnesium , zinc , copper, vitamin d, omega-3 fatty acids, vitamin e and iron capsule, gelatin coated

  • NDC Code(s): 0642-0070-01, 0642-0070-30
  • Packager: Everett Laboratories, Inc.
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

Drug Label Information

Updated 05/11

If you are a consumer or patient please visit this version.

  • BOXED WARNING(What is this?)

    Boxed Warning

    WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.  Keep this product out of the reach of children.  In case of accidental overdose, call a doctor or a Poison Control Center immediately.

    Close
  • Contraindications

    Vitafol-One is contraindicated in patients with hypersensitivity to any of its components or color additives.

    Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid.

    Iron Therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver.

    Cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (Vitamin B12).

    Close
  • WARNINGS/PRECAUTIONS:

    Vitafol-One should be used with caution in patients with known sensitivity or allergy to soy.

    Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kigney stones.  High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues.  Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased risk of heart disease can occur.

    Iodine should be used with caution in patients with an overactive thyroid.

    Prolonged use of iron salts may produce iron storage disease.

    Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive.

    The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency.

    Consumption of more than 3 grams of omega-3 fatty acids per day from all sources may lead to excessive bleeding.  Supplemental intake of omega-3 fatty acids such as DHA exceeding 2 grams per day is not recommended.

    Avoid Overdosage.  Keep out of the reach of children.

    Drug Interactions:

    Medications for an overactive thyroid (anti-thyroid drugs) used in conjunction with iodine supplementation may lead to hypothyroidism.

    Medications for hypertension used in conjunction with iodine supplementation may increase potassium.

    High doses of folic acid may result in decreased serum levels of the anticonvulsant drugs;carbamazepine, fosphenytoin, phenytoin, phenobarbitol, valproic acid.  Folic acid may decrease a patient's response to methotrexate.

    Vitamin D supplementation should not be given with large amounts of calcium in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones.

    Zinc can inhibit the absorption of certain antibiotics; taken at least 2 hours apart to minimize interactions.

    Consult appropriate references for additional specific vitamin-drug interactions.

    Information for Patients: Patients should be counseled to disclose all medical conditions, including use of all medications, vitamins and supplements, pregnancy, and breast-feeding.

    Pediatric Use: Not for pediatric use. 


    Adverse Reactions

    Adverse reactions have been reported with specific vitamins and minerals, but generally at doses substantially higher than those in Vitafol-One.  However, allergic and idiosyncratic reactions are possible at any dose.  Reported adverse events include skin ailments, gastrointestinal complaints, glucose abnormalities, and visual problems.

    Close
  • Dosage and Administration

    Before, during and after pregnancy, one softgel capsule daily, or as directed by a physician.

    Close
  • How Supplied

    Vitafol-One is available as a dark blue, oval shaped softgel capsule imprinted "EV0070".  Avialable in Box of Unit-Dose pack of 30 (5 child resistant blister cards of 6 softgel capsules), (NDC 0642-0070-30) and as professional samples (NDC 0642-0070-01).

    Store at room temperature, approximately 15-30C (59-86F), avoid excessive heat.

    Rx Only

    Manufactured for

    EVERETT LABORATORIES, INC.


    West Orange, NJ 07052

    1-877-324-9349

    Close
  • Principal Display Panel
  • Principal Display Panel
  • INGREDIENTS AND APPEARANCE
    VITAFOL  ONE
    prenatal supplement with dha capsule, gelatin coated
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0642-0070
    Route of Administration ORAL DEA Schedule     
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Vitamin A (Beta Carotene) Beta Carotene 1100 [iU]
    Ascorbic Acid (Ascorbic Acid) Ascorbic Acid 30 mg
    Thiamine Mononitrate (Thiamine ) Thiamine Mononitrate 1.6 mg
    Riboflavin (Riboflavin) Riboflavin 1.8 mg
    Niacin (Niacinamide) Niacinamide 15 mg
    Pyridoxine Hydrochloride (Pyridoxine) Pyridoxine 2.5  mg
    Cyanocobalamin (Cyanocobalamin) Cyanocobalamin .012 mg
    Folic Acid (Folic Acid) Folic Acid 1 mg
    Iodine (Iodine) Iodine 0.150 mg
    Magnesium (Magnesium Oxide) Magnesium Oxide 20 mg
    Zinc (Zinc Oxide) Zinc Oxide 25 mg
    Copper (Cupric Oxide) Cupric Oxide 2 mg
    Vitamin D (Cholecalciferol) Cholecalciferol 1000 [iU]
    Omega-3 Fatty Acids (Doconexent) Doconexent 200 mg
    Vitamin E (Alpha-Tocopherol) Alpha-Tocopherol 20 [iU]
    Iron (Iron) Iron 29 mg
    Inactive Ingredients
    Ingredient Name Strength
    Gelatin  
    Sorbitol  
    Glycerin  
    Soybean Oil  
    Water  
    Yellow Wax  
    Anhydrous Dibasic Calcium Phosphate  
    Lecithin, Soybean  
    Titanium Dioxide  
    Sodium Thiosulfate  
    Sunflower Oil  
    Tocopherol  
    Ascorbyl palmitate  
    Caramel  
    FD&C Blue NO. 1  
    Corn Oil  
    Product Characteristics
    Color blue (Dark Blue) Score no score
    Shape OVAL (size 12 Oval Capsule) Size 10mm
    Flavor Imprint Code EV0070
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:0642-0070-30 5 in 1 BOX
    1 6 in 1 BLISTER PACK
    2 NDC:0642-0070-01 1 in 1 BOX
    2 4 in 1 BLISTER PACK
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    unapproved drug other 06/13/2011
    Labeler - Everett Laboratories, Inc. (071170534)
    Establishment
    Name Address ID/FEI Business Operations
    Intergel Pharmaceutical Inc 964464114 manufacture
    Establishment
    Name Address ID/FEI Business Operations
    Nutra-Med Packaging, Inc. 022004902 pack
    Close